1. Timmis A. Acute coronary syndromes. BMJ. 2015 Oct 20;351:h5153.
2. Bhatt DL. Percutaneous coronary intervention in 2018. JAMA. 2018 May 22;319(20):2127–8.
3. Giannini F, Candilio L, Mitomo S, Ruparelia N, Chieffo A, Baldetti L, et al. A practical approach to the management of complications during percutaneous coronary intervention. JACC Cardiovasc Interv. 2018 Sep 24;11(18):1797–810.
4. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients With ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2016 Mar 15;67(10):1235–50.
5. Grifoni E, Gori AM, Giusti B, Valenti R, Migliorini A, Basili S, et al. On-treatment platelet reactivity is a predictor of adverse events in peripheral artery disease patients undergoing percutaneous angioplasty. Eur J Vasc Endovasc Surg. 2018 Oct;56(4):545–52.